π
|
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.
25 auth.
L. Laurent,
I. Ulitsky,
Ileana Slavin,
H. Tran,
A. Schork,
Robert Morey,
Candace L. Lynch,
Julie V. Harness,
Sunray Lee,
M. J. Barrero,
Sherman Ku,
M. Martynova,
R. Semechkin,
V. Galat,
J. Gottesfeld,
...
J. I. IzpisΓΊa Belmonte,
C. Murry,
H. Keirstead,
Hyun-sook Park,
U. Schmidt,
A. Laslett,
F. Muller,
C. Nievergelt,
R. Shamir,
J. Loring
|
9 |
2011 |
9 π
|
π¬
|
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu,
V. Galat,
Yekaterina Galat4,
Yoo-Kyung Lee,
D. Wainwright,
Jennifer D. Wu
|
8 |
2021 |
8 π¬
|
π
|
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.
24 auth.
Kristopher L. Nazor,
G. Altun,
Candace L. Lynch,
H. Tran,
Julie V. Harness,
Ileana Slavin,
I. Garitaonandia,
F. MuΜller,
Yu-Chieh Wang,
F. Boscolo,
...
Eyitayo Fakunle,
Biljana Dumevska,
Sunray Lee,
H. Park,
T. Olee,
D. DβLima,
R. Semechkin,
M. Parast,
V. Galat,
A. Laslett,
U. Schmidt,
H. Keirstead,
J. Loring,
L. Laurent
|
8 |
2012 |
8 π
|
π
|
Genome-wide quantitative assessment of variation in DNA methylation patterns
10 auth.
Hehuang Xie,
Min Wang,
A. de Andrade,
Maria de F. Bonaldo,
V. Galat,
K. Arndt,
...
V. Rajaram,
S. Goldman,
T. Tomita,
M. Soares
|
6 |
2011 |
6 π
|
π
|
Chromatin-enriched lncRNAs can act as cell-type specific activators of proximal gene transcription
8 auth.
Michael S. Werner,
M. Sullivan,
Rohan N. Shah,
Rangarajan D. Nadadur,
Adrian T Grzybowski,
V. Galat,
...
I. Moskowitz,
A. Ruthenburg
|
6 |
2017 |
6 π
|
π
|
Disruption of GRIN2B Impairs Differentiation in Human Neurons
19 auth.
Scott C. Bell,
G. Maussion,
Malvin Jefri,
Huashan Peng,
J. ThΓ©roux,
Heika Silveira,
Vincent Soubannier,
Hanrong Wu,
P. Hu,
E. Galat,
...
S. Torres-Platas,
Camille Boudreau-Pinsonneault,
L. OβLeary,
V. Galat,
G. Turecki,
Thomas M. Durcan,
E. Fon,
N. Mechawar,
C. Ernst
|
5 |
2018 |
5 π
|
π
|
Restricted ethnic diversity in human embryonic stem cell lines
13 auth.
L. Laurent,
C. Nievergelt,
Candace L. Lynch,
Eyitayo Fakunle,
Julie V. Harness,
U. Schmidt,
V. Galat,
A. Laslett,
T. Otonkoski,
H. Keirstead,
...
A. Schork,
Hyun-sook Park,
J. Loring
|
5 |
2010 |
5 π
|
π
|
Isolation of Oct4-Expressing Extraembryonic Endoderm Precursor Cell Lines
8 auth.
B. Debeb,
V. Galat,
Jessica Epple-Farmer,
S. Iannaccone,
W. Woodward,
M. Bader,
...
P. Iannaccone,
B. Binas
|
5 |
2009 |
5 π
|
π
|
Human embryonic stem cell lines with genetic disorders.
7 auth.
Y. Verlinsky,
N. Strelchenko,
V. Kukharenko,
S. Rechitsky,
O. Verlinsky,
V. Galat,
...
A. Kuliev
|
5 |
2005 |
5 π
|
π
|
Cancer hallmarks in induced pluripotent cells: New insights
8 auth.
S. Malchenko,
V. Galat,
E. Seftor,
E. Vanin,
F. Costa,
Richard E. B. Seftor,
...
M. Soares,
M. Hendrix
|
5 |
2010 |
5 π
|
π’
|
Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential
7 auth.
Yekaterina Galat,
S. Dambaeva,
Irina A. Elcheva,
A. Khanolkar,
K. Beaman,
P. Iannaccone,
...
V. Galat
|
5 |
2017 |
5 π’
|